Citations Report - Cardiovascular Pharmacology: Open Access

Cardiovascular Pharmacology: Open Access : Citations & Metrics Report

Articles published in Cardiovascular Pharmacology: Open Access have been cited by esteemed scholars and scientists all around the world. Cardiovascular Pharmacology: Open Access has got h-index 6, which means every article in Cardiovascular Pharmacology: Open Access has got 6 average citations.

Following are the list of articles that have cited the articles published in Cardiovascular Pharmacology: Open Access.

	2020	2019	2018	2017	2016
Year wise published articles	8	10	21	31	37
Year wise citations received	26	27	28	23	35

Journal total citations count	184
Journal impact factor	0.84
Journal 5 years impact factor	1.30
Journal cite score	1.49
Journal h-index	6
Journal h-index since 2016	6

Important citations

Zembroski R (2018) Rebuild: Five Proven Steps to Move from Diagnosis to Recovery and be Healthier Than Before. HarperCollins. View at Publisher View at Google Scholar
Mittapally VK, Lanka D (2015) Clinical Illness and Outcomes in Patients with Severe CommunityAcquired Pneumonia: A Prospective Study. J Med Health Sci 4. View at Publisher View at Google Scholar
Hassan M, Ellahham S, Ibrahim HS (2019) Frailty in Heart Failure: A Coalesce of International Guidelines. J Clin Exp Cardiolog 10:2. View at Publisher View at Google Scholar
Wong CK (2016) From Arctic to Antarctic: Is There any Remaining Role for Platelet Function Testing to Tailor Therapy after Coronary Stent Implantation. Cardiovasc Pharm Open Access 5: e132. View at Publisher View at Google Scholar
Wong CK (2015) Time for a Reappraisal: How much has the Last 10 Years of Mainstream STEMI Research Impacted on STEMI Outcome?. Cardiovascular Pharmacology: Open Access. View at Publisher View at Google Scholar
Kang YC, Chen MH, Wang LY, Huang MP (2013) Cardiotoxicity Induced by a Single Oral Therapeutic Dose of Verapamil in a Patient with End-Stage Renal Disease and Liver Cirrhosis. Acta Nephrologica 27: 225-230. View at Publisher View at Google Scholar
é»ƒä¾å©·, æž—æ…ˆèŠ³, æˆ´æ—å¿—, å³æŸç¿°, æž—æ£å¸¸ (2015) å–®æ¬¡é˜»åŠ›é‹å‹•å°å¹´è¼•è‚¥èƒ–ç”·æ€§å‹•è„ˆç¡¬åŒ–æŒ‡æ¨™çš„å½±éŸ¿. å¤§å°ˆé«”è‚²å¸åˆŠ 17:96-107. View at Publisher View at Google Scholar
Kotani K (2016) Plasma lipoprotein-associated phospholipase A2 levels correlated with the cardio-ankle vascular index in long-term type 2 diabetes mellitus patients. International journal of molecular sciences 17: 634. View at Publisher View at Google Scholar
Sorokin A, Kotani K, Bushueva O, Taniguchi N, Lazarenko V (2015) The cardio-ankle vascular index and ankle-brachial index in young Russians. J Atheroscler Thromb 22: 211-218. View at Publisher View at Google Scholar
Parsons XH (2016) Human pluripotent stem cell-based PluriXcel technology platforms provide stem cell treatment development and manufacturing innovations for progressing to the clinic. J Regen Ther 1: 1-8. View at Publisher View at Google Scholar
Parsons XH (2013) The designation of human cardiac stem cell therapy products for human trials. J Clin Trial Cardiol 1: 02. View at Publisher View at Google Scholar
Parsons XH (2014) The openness of pluripotent epigenome–defining the genomic integrity of stemness for regenerative medicine. Int J Cancer Ther Oncol 2: 20114. View at Publisher View at Google Scholar
Parsons XH (2016) Direct conversion of pluripotent human embryonic stem cells under defined culture conditions into human neuronal or cardiomyocyte cell therapy derivatives. Human Embryonic Stem Cell Protocols 299-318. View at Publisher View at Google Scholar
Parsons XH (2016) Journal of Regenerative Therapeutics Volume 1, Issue 1, October 2016, Pages 1–8. Journal of Regenerative Therapeutics. 1 : 1-8. View at Publisher View at Google Scholar
Parsons XH (2016) Human pluripotent stem cell-based PluriXcel technology platforms provide stem cell treatment development and manufacturing innovations for progressing to the clinic. J Regen Ther 1: 1-8. View at Publisher View at Google Scholar
Parsons XH (2013) The designation of human cardiac stem cell therapy products for human trials. J Clin Trial Cardiol 1: 02. View at Publisher View at Google Scholar
Parsons XH (2014) The openness of pluripotent epigenome–defining the genomic integrity of stemness for regenerative medicine. Int J Cancer Ther Oncol 2: 20114. View at Publisher View at Google Scholar
Parsons XH (2016) Direct conversion of pluripotent human embryonic stem cells under defined culture conditions into human neuronal or cardiomyocyte cell therapy derivatives. Human Embryonic Stem Cell Protocols 16: 299-318. View at Publisher View at Google Scholar
Brown SA, Nhola L, Herrmann J (2016) Cardiovascular Toxicities of Small Molecule TKIs: An Opportunity for Systemsâ€Based Approaches. Clinical Pharmacology & Therapeutics. View at Publisher View at Google Scholar
Yaniv Y, Ahmet I, Tsutsui K, Behar J, Moen JM, et al. (2016) Deterioration of autonomic neuronal receptor signaling and mechanisms intrinsic to heart pacemaker cells contribute to ageâ€associated alterations in heart rate variability in vivo. Aging cell 15: 716-724. View at Publisher View at Google Scholar
Prev 1 2 3 4 Next »

Cardiovascular Pharmacology: Open Access
Open Access

Cardiovascular Pharmacology: Open Access : Citations & Metrics Report

Important citations

Zembroski R (2018) Rebuild: Five Proven Steps to Move from Diagnosis to Recovery and be Healthier Than Before. HarperCollins.

Mittapally VK, Lanka D (2015) Clinical Illness and Outcomes in Patients with Severe CommunityAcquired Pneumonia: A Prospective Study. J Med Health Sci 4.

Hassan M, Ellahham S, Ibrahim HS (2019) Frailty in Heart Failure: A Coalesce of International Guidelines. J Clin Exp Cardiolog 10:2.

Wong CK (2016) From Arctic to Antarctic: Is There any Remaining Role for Platelet Function Testing to Tailor Therapy after Coronary Stent Implantation. Cardiovasc Pharm Open Access 5: e132.

Wong CK (2015) Time for a Reappraisal: How much has the Last 10 Years of Mainstream STEMI Research Impacted on STEMI Outcome?. Cardiovascular Pharmacology: Open Access.

Kang YC, Chen MH, Wang LY, Huang MP (2013) Cardiotoxicity Induced by a Single Oral Therapeutic Dose of Verapamil in a Patient with End-Stage Renal Disease and Liver Cirrhosis. Acta Nephrologica 27: 225-230.

é»ƒä¾å©·, æž—æ…ˆèŠ³, æˆ´æ—å¿—, å³æŸç¿°, æž—æ£å¸¸ (2015) å–®æ¬¡é˜»åŠ›é‹å‹•å°å¹´è¼•è‚¥èƒ–ç”·æ€§å‹•è„ˆç¡¬åŒ–æŒ‡æ¨™çš„å½±éŸ¿. å¤§å°ˆé«”è‚²å¸åˆŠ 17:96-107.

Kotani K (2016) Plasma lipoprotein-associated phospholipase A2 levels correlated with the cardio-ankle vascular index in long-term type 2 diabetes mellitus patients. International journal of molecular sciences 17: 634.

Sorokin A, Kotani K, Bushueva O, Taniguchi N, Lazarenko V (2015) The cardio-ankle vascular index and ankle-brachial index in young Russians. J Atheroscler Thromb 22: 211-218.

Parsons XH (2016) Human pluripotent stem cell-based PluriXcel technology platforms provide stem cell treatment development and manufacturing innovations for progressing to the clinic. J Regen Ther 1: 1-8.

Parsons XH (2013) The designation of human cardiac stem cell therapy products for human trials. J Clin Trial Cardiol 1: 02.

Parsons XH (2014) The openness of pluripotent epigenome–defining the genomic integrity of stemness for regenerative medicine. Int J Cancer Ther Oncol 2: 20114.

Parsons XH (2016) Direct conversion of pluripotent human embryonic stem cells under defined culture conditions into human neuronal or cardiomyocyte cell therapy derivatives. Human Embryonic Stem Cell Protocols 299-318.

Parsons XH (2016) Journal of Regenerative Therapeutics Volume 1, Issue 1, October 2016, Pages 1–8. Journal of Regenerative Therapeutics. 1 : 1-8.

Parsons XH (2016) Human pluripotent stem cell-based PluriXcel technology platforms provide stem cell treatment development and manufacturing innovations for progressing to the clinic. J Regen Ther 1: 1-8.

Parsons XH (2013) The designation of human cardiac stem cell therapy products for human trials. J Clin Trial Cardiol 1: 02.

Parsons XH (2014) The openness of pluripotent epigenome–defining the genomic integrity of stemness for regenerative medicine. Int J Cancer Ther Oncol 2: 20114.

Parsons XH (2016) Direct conversion of pluripotent human embryonic stem cells under defined culture conditions into human neuronal or cardiomyocyte cell therapy derivatives. Human Embryonic Stem Cell Protocols 16: 299-318.

Brown SA, Nhola L, Herrmann J (2016) Cardiovascular Toxicities of Small Molecule TKIs: An Opportunity for Systemsâ€Based Approaches. Clinical Pharmacology & Therapeutics.

Yaniv Y, Ahmet I, Tsutsui K, Behar J, Moen JM, et al. (2016) Deterioration of autonomic neuronal receptor signaling and mechanisms intrinsic to heart pacemaker cells contribute to ageâ€associated alterations in heart rate variability in vivo. Aging cell 15: 716-724.

Relevant Topics

Cardiovascular Pharmacology: Open AccessOpen Access

Cardiovascular Pharmacology: Open Access : Citations & Metrics Report

Important citations

Zembroski R (2018) Rebuild: Five Proven Steps to Move from Diagnosis to Recovery and be Healthier Than Before. HarperCollins.

Mittapally VK, Lanka D (2015) Clinical Illness and Outcomes in Patients with Severe CommunityAcquired Pneumonia: A Prospective Study. J Med Health Sci 4.

Hassan M, Ellahham S, Ibrahim HS (2019) Frailty in Heart Failure: A Coalesce of International Guidelines. J Clin Exp Cardiolog 10:2.

Wong CK (2016) From Arctic to Antarctic: Is There any Remaining Role for Platelet Function Testing to Tailor Therapy after Coronary Stent Implantation. Cardiovasc Pharm Open Access 5: e132.

Wong CK (2015) Time for a Reappraisal: How much has the Last 10 Years of Mainstream STEMI Research Impacted on STEMI Outcome?. Cardiovascular Pharmacology: Open Access.

Kang YC, Chen MH, Wang LY, Huang MP (2013) Cardiotoxicity Induced by a Single Oral Therapeutic Dose of Verapamil in a Patient with End-Stage Renal Disease and Liver Cirrhosis. Acta Nephrologica 27: 225-230.

Kotani K (2016) Plasma lipoprotein-associated phospholipase A2 levels correlated with the cardio-ankle vascular index in long-term type 2 diabetes mellitus patients. International journal of molecular sciences 17: 634.

Sorokin A, Kotani K, Bushueva O, Taniguchi N, Lazarenko V (2015) The cardio-ankle vascular index and ankle-brachial index in young Russians. J Atheroscler Thromb 22: 211-218.

Parsons XH (2016) Human pluripotent stem cell-based PluriXcel technology platforms provide stem cell treatment development and manufacturing innovations for progressing to the clinic. J Regen Ther 1: 1-8.

Parsons XH (2013) The designation of human cardiac stem cell therapy products for human trials. J Clin Trial Cardiol 1: 02.

Parsons XH (2014) The openness of pluripotent epigenome–defining the genomic integrity of stemness for regenerative medicine. Int J Cancer Ther Oncol 2: 20114.

Parsons XH (2016) Direct conversion of pluripotent human embryonic stem cells under defined culture conditions into human neuronal or cardiomyocyte cell therapy derivatives. Human Embryonic Stem Cell Protocols 299-318.

Parsons XH (2016) Journal of Regenerative Therapeutics Volume 1, Issue 1, October 2016, Pages 1–8. Journal of Regenerative Therapeutics. 1 : 1-8.

Parsons XH (2016) Human pluripotent stem cell-based PluriXcel technology platforms provide stem cell treatment development and manufacturing innovations for progressing to the clinic. J Regen Ther 1: 1-8.

Parsons XH (2013) The designation of human cardiac stem cell therapy products for human trials. J Clin Trial Cardiol 1: 02.

Parsons XH (2014) The openness of pluripotent epigenome–defining the genomic integrity of stemness for regenerative medicine. Int J Cancer Ther Oncol 2: 20114.

Parsons XH (2016) Direct conversion of pluripotent human embryonic stem cells under defined culture conditions into human neuronal or cardiomyocyte cell therapy derivatives. Human Embryonic Stem Cell Protocols 16: 299-318.

Brown SA, Nhola L, Herrmann J (2016) Cardiovascular Toxicities of Small Molecule TKIs: An Opportunity for Systemsâ€Based Approaches. Clinical Pharmacology & Therapeutics.

Yaniv Y, Ahmet I, Tsutsui K, Behar J, Moen JM, et al. (2016) Deterioration of autonomic neuronal receptor signaling and mechanisms intrinsic to heart pacemaker cells contribute to ageâ€associated alterations in heart rate variability in vivo. Aging cell 15: 716-724.

Relevant Topics

Cardiovascular Pharmacology: Open Access
Open Access

Brown SA, Nhola L, Herrmann J (2016) Cardiovascular Toxicities of Small Molecule TKIs: An Opportunity for Systemsâ€Based Approaches. Clinical Pharmacology & Therapeutics.

Yaniv Y, Ahmet I, Tsutsui K, Behar J, Moen JM, et al. (2016) Deterioration of autonomic neuronal receptor signaling and mechanisms intrinsic to heart pacemaker cells contribute to ageâ€associated alterations in heart rate variability in vivo. Aging cell 15: 716-724.